Celiac disease mechanism and therapies (Homo sapiens)
From WikiPathways
Description
No description
Please use the New WikiPathways
View approved pathways at the new wikipathways.org. This website will shutdown soon.Quality Tags
Ontology Terms
Bibliography
- Vicari AP, Schoepfer AM, Meresse B, Goffin L, Léger O, Josserand S, Guégan N, Yousefi S, Straumann A, Cerf-Bensussan N, Simon HU, Chvatchko Y; ''Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitis.''; MAbs, 2017 PubMed Europe PMC Scholia
- Dieckman T, Koning F, Bouma G; ''Celiac disease: New therapies on the horizon.''; Curr Opin Pharmacol, 2022 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
| View all... |
| Name | Type | Database reference | Comment |
|---|---|---|---|
| AGY | Metabolite | ||
| CALY-002 | Metabolite | ||
| CD4 | GeneProduct | ||
| DHODH | GeneProduct | ||
| Deaminated
gluten peptide | Metabolite | ||
| EGFR | GeneProduct | ||
| GSK3915393 | Metabolite | ||
| GZMB | GeneProduct | ||
| Gluten | Metabolite | ||
| Gluten peptide | Metabolite | ||
| HLA-DQ2 | GeneProduct | ||
| HLA-DQ8 | GeneProduct | ||
| IFNG | GeneProduct | ||
| IL15 | GeneProduct | ||
| IL2 | GeneProduct | ||
| IL21 | GeneProduct | ||
| ITGA4 | GeneProduct | ||
| ITGB7 | GeneProduct | ||
| Inflammation | |||
| KAN-101 | Metabolite | ||
| Larazotide | Metabolite | ||
| Latiglutenase | Metabolite | ||
| Loss of tolerance | |||
| PAR2 | GeneProduct | ||
| PRV-015 | Metabolite | ||
| PTG-100 | Metabolite | ||
| Pyrimidine synthesis | Pathway | ||
| TAK-062 | Metabolite | ||
| TAK-101 | Metabolite | ||
| TG2 | GeneProduct | ||
| TNFA | GeneProduct | ||
| TRA | GeneProduct | ||
| TRB | GeneProduct | ||
| Teriflunomide | Metabolite | ||
| Tolerase G | Metabolite | ||
| ZED1227 | Metabolite |
Annotated Interactions
No annotated interactions
Saving...
